Pharma Journalist -

Teva Pharmaceutical announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for fremanezumab, an anti-calcitonin gene-related…
Read More...

SMi Group are proud to present the 9th Annual RNA Therapeutics conference, taking place on 21st - 22nd February 2018 at Holiday Inn Kensington Forum, London,…
Read More...

Have you seen the complete agenda for the 10th annual Social Media in the Pharmaceutical Industry? Bringing in voices from top pharma companies and social media experts, to educate,…
Read More...

Amgen and Boston Children's Hospital announced that they have entered into a neuroscience research collaboration aimed at identifying novel pain targets based on human genetic analyses.…
Read More...

Exelixis announced that the U.S. Food and Drug Administration (FDA) has determined the company’s supplemental New Drug Application (sNDA) for CABOMETYX®(cabozantinib) for patients with…
Read More...

Takeda Pharmaceutical Company Limited and HemoShear Therapeutics announced a partnership to discover and develop novel therapeutics for liver diseases, including nonalcoholic…
Read More...

GSK announced that the World Health Organization (WHO) has awarded prequalification for the new four-dose vial presentation of Synflorix pneumococcal vaccine targeted mainly for…
Read More...

Miraca Life Sciences continues to expand in clinical pathology: its InformTx™ therapeutic drug monitoring (TDM) has begun the validation process for Renflexis™ (infliximab-abda), a…
Read More...

Ionis Pharmaceuticals, Inc. announced that it has initiated a Phase 1/2a clinical study of IONIS-MAPTRx in patients with mild Alzheimer's disease (AD). Ionis earned a $10 million…
Read More...

TARGET PharmaSolutions announced that Bristol-Myers Squibb (BMY) has extended its strategic partnership for TARGET-NASH to a multi-year agreement.  Bristol-Myers Squibb is committed to…
Read More...